# A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants

> **NCT04243083** · PHASE1 · COMPLETED · sponsor: **TLL Pharmaceutical, LLC** · enrollment: 100 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TLL018 tablet, placebo

## Key facts

- **NCT ID:** NCT04243083
- **Lead sponsor:** TLL Pharmaceutical, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-26
- **Primary completion:** 2020-12-23
- **Final completion:** 2021-01-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04243083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04243083, "A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04243083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*